StockData
Olema Oncology, Inc. logo

Olema Oncology, Inc. (OLMA) stock

OLMANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/30
$7.02−0.13 (-1.82%)

Close on Nov 20, 2026Market cap $614.23MP/E –Yield –

Olema Oncology free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Olema Oncology's free cash flow for the twelve months ending Dec 31, 2024 was -$104.51M. For fiscal 2024 it was -$104.51M.

Annual free cash flow

PeriodPeriod endValueChange
FY2024Dec 31, 2024-$104.51M–
FY2022Dec 31, 2022-$82.43M–
FY2021Dec 31, 2021-$52.27M–
FY2020Dec 31, 2020-$19.92M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2025Sep 30, 2025-$34.53M–
Q4 FY2024Dec 31, 2024-$26.28M–
Q3 FY2024Sep 30, 2024-$27.02M–
Q2 FY2024Jun 30, 2024-$27.56M–
Q1 FY2024Mar 31, 2024-$23.65M–
Q4 FY2022Dec 31, 2022-$19.88M–
Q3 FY2022Sep 30, 2022-$18.13M–
Q2 FY2022Jun 30, 2022-$26.48M–
Q1 FY2022Mar 31, 2022-$17.93M–
Q4 FY2021Dec 31, 2021-$19.30M–
Q3 FY2021Sep 30, 2021-$12.19M–
Q2 FY2021Jun 30, 2021-$9.27M–
Q1 FY2021Mar 31, 2021-$11.50M–
Q4 FY2020Dec 31, 2020-$9.06M–
Q3 FY2020Sep 30, 2020-$7.53M–
Q2 FY2020Jun 30, 2020-$1.19M–
Q1 FY2020Mar 31, 2020-$2.15M–

More Olema Oncology figures

See a number that looks wrong?